Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: October 2007
-
By Jason Derry — Alethia Biotherapeutics Inc. has announced a licensing agreement with the National Research Council Biotechnology Research Institute (NRC-BRI). Under the terms of the agreement, Alethia receives exclusive worldwide rights to a family of monoclonal antibodies that specifically block activity of secreted clusterin. Alethia plans to move the anti-clusterin antibodies, which…
-
By Donald Zuhn — Last week, MorphoSys AG announced that it had been granted U.S. Patent No. 7,264,963. The ‘963 patent, which relates to the preparation of a library of human-derived antibody genes by the use of synthetic consensus sequences that cover the structural repertoire of antibodies encoded in the human genome, is…
-
By Sherri Oslick — Last week, Bristol-Myers Squibb Co. of Princeton, NJ announced that it would acquire biotechnology company Adnexus Therapeutics Inc. of Waltham, MA for $430 million in cash (with an additional $75 million to be paid provided Adnexus meets certain regulatory milestones). Adnexus is a privately held company developing a proprietary…
-
By Kevin E. Noonan — A curious aspect of the recently-promulgated new prosecution rules (see links below) has been the relative silence of the major interest groups in opposition. Perhaps lulled by pundits who declared the new rules "dead" as recently as six months before they were issued, or because the focus was…
-
By Donald Zuhn — On August 28, 2007, we reported that the U.S. Patent and Trademark Office would be adjusting patent fees to reflect fluctuations in the Consumer Price Index (CPI), and that the new fees would become effective on September 30, 2007. Last Friday, the PTO published a notice in the Federal…
Patent Docs 